We heartfully thank the esteemed panel of speakers, the moderator, and all the attendees who collectively contributed to the success of this Navigation Masterclass.
Moderator & Speaker: Dr. Ernesto Santos, Memorial Sloan Kettering Cancer Center New York, USA
Speakers: Dr. Julien Frandon, CHU Nîmes, France Dr. Dimitrios K Filippiadis, UGH Attikon Athens, Greece Dr. Santiago Méndez Alonso, Hospital Universitario Puerta de Hierro Madrid, Spain Prof. Rosario Francesco Grasso, Campus Bio-Medico Rome, Italy Prof. François H. Cornelis, Tenon AP-HP Paris, France
D. Filippiadis, G. Velonakis, A. Mazioti, A. Tsochatzis, T. Vrachliotis, A. Kelekis, N. Kelekis – Medicina
♦ Review of the system: description, intended use, procedure details, main benefits and clinical data
♦ CT-Navigation could be considered as a first option in the diagnosis and/or treatment of lesions in difficult locations, even if further studies are necessary
J. A. Gómez Patiño, S. Méndez Alonso, M. Alfageme, R. González Costero, A. García Suárez, J. González Plaza, V. Perdomo Suriel, M. L. Collado Torres – ECR 2020
♦ Retrospective, comparative study involving 120 patients
♦ The system demonstrated a very high diagnostic success rate
♦ Radiation exposure & needle insertion time were significantly lower in the navigation group
♦ The use of CT-Navigation is efficient, reliable & safe for lung biopsy compared to conventional CT guidance
M. Lanouzière, O. Varbedian, O. Chevallier, L. Griviau, K. Guillen, R. Popoff, S.-L. Aho-Glélé and R. Loffroy – Diagnostics
♦ Case review of seven patients: 4 biopsies (hepatic, pulmonary, retroperitoneal and osseous lesions) and 3 ablations (pulmonary, pancreatic and hepatic carcinomas)
♦ The system was easily operated, facilitated pre-procedure planing and displayed an accurate needle trajectory
♦ Benefits for ablations (higher accuracy, better targeting of small lesions) and biopsies (fewer CT controls) without significant post-procedure complications
Yadiel Sánchez, BA, Dmitry S. Trifanov, MD, Taj M. Kattapuram, MD, Haiyang Tao, MD, PhD, Anand M. Prabhakar, MD, MBA, Ronald S. Arellano, MD, Raul N. Uppot, MD – Journal of the American College of Radiology
♦ Prospective controlled multicenter study protocol (500 patients maximum)
♦ The aim is to assess the safety, efficacy and performance within the 2 patient groups
RC. Rouchy, A. Moreau-Gaudry, E. Chipon, S. Aubry, L. Pazart, B. Lapuyade, M. Durand, M. Hajjam, S. Pottier, B. Renard, R. Logier, X. Orry, A. Cherifi, E. Quehen, G. Kervio, O. Favelle, F. Patat, E. De Kerviler, C. Hughes, M. Medici, J. Ghelfi, A. Mounier & I. Bricault – Trials
♦ Prospective controlled study involving 120 patients
♦ Accuracy improved by a factor of 2 (when using the navigation system)
♦ Fewer acquisition scans: 2 vs 3 (when using the navigation system)
